Cash Flow from Operating Activities: A company's cash flows from operations.
Cytokinetics, Incorporated (CYTK) had Cash Flow from Operating Activities of $-305.30M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$28.62M |
|
$-198.76M |
|
$5.59M |
|
$23.03M |
|
$207.80M |
|
$-179.17M |
|
$-19.59M |
|
$-198.76M |
|
$-198.76M |
|
$-198.76M |
|
$-198.76M |
|
$-198.76M |
|
$-198.76M |
|
$-179.17M |
|
$-175.54M |
|
132.09M |
|
132.09M |
|
$-1.50 |
|
$-1.50 |
|
| Balance Sheet Financials | |
$1.21B |
|
$78.92M |
|
$716.06M |
|
$1.92B |
|
$181.43M |
|
$1.12B |
|
$1.92B |
|
$2.10B |
|
$-173.49M |
|
$-173.49M |
|
$-173.49M |
|
138.76M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-305.30M |
$-361.51M |
|
$800.63M |
|
$125.63M |
|
$258.38M |
|
$132.75M |
|
$66.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.66 |
|
-- |
|
-- |
|
1.18 |
|
-6.61 |
|
80.46% |
|
-625.95% |
|
-625.95% |
|
-- |
|
-694.39% |
|
-694.39% |
|
$-315.56M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
14.72 |
|
1.17 |
|
76.82 |
|
114.57% |
|
114.57% |
|
-10.33% |
|
-21.01% |
|
$-1.25 |
|
$-2.39 |
|
$-2.31 |
|